Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
NeuroBo Pharmaceuticals ( (NRBO) ) just unveiled an update.
NeuroBo Pharmaceuticals is set to rebrand as MetaVia Inc. on November 29, 2024, with a new Nasdaq ticker symbol, MTVA, reflecting its focus on cardiometabolic diseases. This strategic realignment accompanies significant clinical milestones, including trials for DA-1241 and DA-1726, targeting conditions like obesity and MASH. Despite the name change, shareholders’ rights remain unaffected, and operations continue as usual, supported by a strong financing background.
Learn more about NRBO stock on TipRanks’ Stock Analysis page.
